Alfred Morgenstern Selected Research

Carbon

1/2021

Diverse metabolic response of cancer cells treated with a 213Bi-anti-EGFR-immunoconjugate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alfred Morgenstern Research Topics

Disease

82	Neoplasms (Cancer) 03/2024 - 11/2004
37	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 04/2006
11	Carcinoma (Carcinomatosis) 01/2023 - 10/2005
10	Glioma (Gliomas) 03/2024 - 05/2016
8	Glioblastoma (Glioblastoma Multiforme) 05/2024 - 01/2018
8	Neoplasm Metastasis (Metastasis) 01/2023 - 12/2009
8	Multiple Myeloma 01/2022 - 04/2007
8	Ovarian Neoplasms (Ovarian Cancer) 02/2020 - 03/2006
7	Brain Neoplasms (Brain Tumor) 10/2023 - 01/2018
7	Breast Neoplasms (Breast Cancer) 04/2020 - 12/2009
7	Peritoneal Neoplasms 01/2018 - 06/2007
6	Urinary Bladder Neoplasms (Bladder Cancer) 03/2024 - 10/2009
6	Neoplasm Micrometastasis 01/2023 - 12/2006
6	Infections 01/2014 - 04/2009
5	Melanoma (Melanoma, Malignant) 03/2024 - 06/2007
5	Neuroendocrine Tumors (Neuroendocrine Tumor) 06/2023 - 01/2018
4	Ascites 12/2017 - 01/2008
4	Stomach Neoplasms (Stomach Cancer) 08/2007 - 10/2005
3	Xerostomia 10/2021 - 01/2018
3	Residual Neoplasm 01/2021 - 08/2005
3	Pancreatic Neoplasms (Pancreatic Cancer) 10/2014 - 01/2005
2	Lymphoma (Lymphomas) 03/2024 - 11/2004
2	Inflammation (Inflammations) 12/2022 - 01/2019
2	Disease Progression 01/2021 - 09/2013
2	Leukemia 01/2020 - 03/2007
2	Body Weight (Weight, Body) 12/2017 - 01/2017
2	Communicable Diseases (Infectious Diseases) 07/2012 - 05/2006
2	Necrosis 04/2012 - 02/2009
2	Cryptococcosis 01/2012 - 04/2009
2	Mycoses (Diseases, Fungus) 11/2009 - 05/2006
1	Astrocytoma (Pilocytic Astrocytoma) 10/2023
1	Oligodendroglioma 10/2023
1	Renal Cell Carcinoma (Grawitz Tumor) 05/2022

Drug/Important Bio-Agent (IBA)

32	Radioisotopes (Radionuclides)IBA 01/2024 - 03/2006
25	AntigensIBA 01/2024 - 08/2005
19	Monoclonal AntibodiesIBA 04/2020 - 10/2005
12	LigandsIBA 05/2024 - 01/2008
12	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 10/2023 - 03/2016
12	Immunoconjugates (Immunoconjugate)IBA 05/2022 - 12/2006
9	Substance PIBA 05/2024 - 05/2016
8	Peptides (Polypeptides)IBA 10/2023 - 01/2008
8	AntibodiesIBA 03/2021 - 05/2006
7	Actinium-225IBA 05/2024 - 01/2016
6	Bismuth-213IBA 03/2024 - 03/2006
6	Trastuzumab (Herceptin)FDA Link 12/2022 - 03/2006
5	Single-Domain AntibodiesIBA 01/2023 - 04/2020
4	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 06/2023 - 01/2014
4	Peptide Receptors (Peptide Receptor)IBA 06/2023 - 02/2011
4	ErbB Receptors (EGF Receptor)IBA 12/2022 - 10/2009
4	LipidsIBA 01/2022 - 01/2016
4	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 10/2013
4	Proteins (Proteins, Gene)FDA Link 12/2017 - 06/2007
3	RadiopharmaceuticalsIBA 10/2023 - 05/2016
3	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2023 - 12/2018
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 08/2006
3	Prostate-Specific Antigen (Semenogelase)IBA 10/2021 - 01/2018
3	Pentetic Acid (DTPA)FDA LinkGeneric 04/2020 - 05/2009
3	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 03/2020 - 04/2017
3	LuciferasesIBA 01/2015 - 10/2009
3	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 02/2009 - 01/2005
2	Capsules (Microcapsules)IBA 10/2023 - 09/2013
2	InterferonsIBA 01/2023 - 01/2022
2	CytokinesIBA 01/2023 - 01/2022
2	Lutetium-177IBA 05/2022 - 01/2015
2	Therapeutic UsesIBA 03/2021 - 01/2017
2	Chelating AgentsIBA 04/2020 - 05/2016
2	Peptide FragmentsIBA 01/2018 - 04/2017
2	substance P (5-11)IBA 01/2018 - 04/2017
2	Carcinoembryonic AntigenIBA 01/2017 - 10/2005
2	Liposomes (Liposome)IBA 01/2017 - 01/2014
2	Neoplasm Antigens (Tumor Antigens)IBA 04/2016 - 01/2015
2	(213)Bi-DTPA-F3IBA 12/2012 - 04/2012
2	3-O-(methylthiomethyl)apiitol tetraacetateIBA 02/2009 - 12/2006
2	Plasminogen Activators (Plasminogen Activator)IBA 02/2009 - 01/2005
2	Urokinase Plasminogen Activator ReceptorsIBA 01/2008 - 01/2005
2	Plasminogen InactivatorsIBA 04/2006 - 01/2005
1	PSMA I&TIBA 01/2024
1	yttrium(III)- 1,4,7,10- tetraazacyclotetradecane- N,N',N'',N'''- tetraacetic acidIBA 10/2023
1	Hormones (Hormone)IBA 01/2023
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2023
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2023
1	OvalbuminIBA 01/2023
1	ChemokinesIBA 01/2023
1	Carbonic Anhydrase IXIBA 05/2022
1	Extracellular Matrix ProteinsIBA 01/2022
1	ParaproteinsIBA 01/2022
1	TenascinIBA 01/2022
1	Interleukin-2 (IL2)IBA 01/2022

Therapy/Procedure

87	Therapeutics 05/2024 - 11/2004
33	Radioimmunotherapy 12/2022 - 11/2004
21	Castration 01/2024 - 12/2016
11	Radiotherapy 01/2023 - 11/2004
5	Aftercare (After-Treatment) 12/2017 - 08/2006
4	Drug Therapy (Chemotherapy) 09/2019 - 08/2006
3	Catheters 10/2023 - 05/2016
2	Precision Medicine 01/2022 - 01/2018
2	Injections 01/2019 - 08/2005
2	Cytoreduction Surgical Procedures 01/2018 - 01/2015
2	Electrocoagulation (Electrocautery) 01/2015 - 10/2009
2	Immunotherapy 01/2015 - 11/2010